Clinical Trial Detail

NCT ID NCT03668431
Title Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Massachusetts General Hospital
Indications

colorectal cancer

Therapies

Dabrafenib + Spartalizumab + Trametinib

Age Groups: adult senior

Additional content available in CKB BOOST